Transforming Growth Factor Beta 1 Market to Garner USD 2756.3 Million by 2026 at 11.1% CAGR, COVID-19 Impact and Global Analysis by The Market Reports

The global Transforming Growth Factor Beta 1 market was valued at US$ 1308.8 million in 2019 and is expected to reach US$ 2756.3 million by the end of 2026, growing at a CAGR of 11.1% during 2021-2026.

Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene

North America is the largest consumption place, with a consumption market share nearly 61.5% In 2018. Following North America, Asia-Pacific and Europe is the second two largest consumption places with the consumption market share of 18% and 17%, respectively.

Global Transforming Growth Factor Beta 1 Market: Drivers and Restrains

The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2016 to 2027. This section mentions the volume of production by region from 2016 to 2027. Pricing analysis is included in the report according to each type from the year 2016 to 2027, manufacturer from 2016 to 2021, region from 2016 to 2021, and global price from 2016 to 2027.

A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.

Global Transforming Growth Factor Beta 1 Market: Segment Analysis

The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027.

Key Companies profiled in this report are Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp, Isarna Therapeutics GmbH, Scholar Rock, Sirnaomics Inc, Eli Lilly and Co, Formation Biologics Inc, Novartis AG and more in terms of market share by sales, revenue, average pricing, product type, margins, recent developments etc.

Find more details at:

Segment by Type

  • Pirfenidone
  • Galunisertib
  • Others

Segment by Application

  • IPF
  • Cancer
  • Others

Table of Content:

1 Transforming Growth Factor Beta 1 Market Overview

2 Transforming Growth Factor Beta 1 Market Competition by Manufacturers

3 Transforming Growth Factor Beta 1 Retrospective Market Scenario by Region

4 Global Transforming Growth Factor Beta 1 Historic Market Analysis by Type

5 Global Transforming Growth Factor Beta 1 Historic Market Analysis by Application

6 Key Companies Profiled

7 Transforming Growth Factor Beta 1 Manufacturing Cost Analysis

8 Marketing Channel, Distributors and Customers

9 Transforming Growth Factor Beta 1 Market Dynamics

10 Global Market Forecast

11 Research Finding and Conclusion

12 Methodology and Data Source

Media Contact

Company Name: The Market Reports

Contact Person: Shirish Gupta


Phone: +1-631-407-1315


Leave a Reply

Your email address will not be published. Required fields are marked *